Literature DB >> 22013796

[Clinical study on the treatment of knee osteoarthritis by wangbi tablet].

Xin-zhong Kang1, Qi-fu Wu, Hong-yu Jie.   

Abstract

OBJECTIVE: To observe the clinical efficacy of Wangbi Tablet (WT) on the treatment of knee osteoarthritis (KOA), and to study its treatment program by integrative medicine.
METHODS: The randomized, parallel control, and multi-center clinical observation method was used. 160 KOA patients of Gan-Shen deficiency complicated with stasis-blood blockade syndrome were assigned to three groups. Group A (72 cases) was treated by WT, Group B (42 cases) was treated by Votalin Tablet, and Group C (46 cases) was treated by WT + Votalin Tablet. All patients were treated for two months. Before and after treatment the clinical symptoms, the knee function activity, adverse reactions were observed and recorded. Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) of each patient were respectively detected, statistically analyzed and compared.
RESULTS: After eight weeks of treatment significant difference was shown in the time of morning stiffness in joints, joint tendemess, swelling, pain, joint functional activities, ESR, and CRP between Group A and Group B (P<0.01). Besides, better effects were obtained in Group C (P<0.01). Improvement of ESR and CRP: They were obviously improved in the three groups after treatment (P<0.01). As for the markedly effective rate, better effects were obtained in Group C (P<0.05).
CONCLUSIONS: In the treatment of KOA, WT showed favorable effects with no obvious adverse reaction. The combination of WT and Voltaren Tablet was significantly superior to use of WT or Votalin Tablet alone. It could reduce the dosage of Voltaren Tablet and avoid adverse reactions of the gastrointestinal tract.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22013796

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  4 in total

Review 1.  Oral herbal therapies for treating osteoarthritis.

Authors:  Melainie Cameron; Sigrun Chrubasik
Journal:  Cochrane Database Syst Rev       Date:  2014-05-22

2.  Identification of the Main Active Components and Mechanism of Wang Bi Tablet in Treating Rheumatoid Arthritis Based on Integrative Pharmacology.

Authors:  Yuanyuan Jiao; Jia Xu; Hong Chen; Qiuyan Guo; Xiaofang Deng; Tong Zhang; Jingbo Zhang; Chenjing Shi; Ping Wang
Journal:  Front Pharmacol       Date:  2021-06-04       Impact factor: 5.810

Review 3.  Effectiveness and Safety of Manufactured Chinese Herbal Formula for Knee Osteoarthritis: Insights from a Systematic Review.

Authors:  Liguo Zhu; Shaofeng Yang; Shangquan Wang; Hao Gong; Linghui Li; Xu Wei
Journal:  Evid Based Complement Alternat Med       Date:  2015-11-01       Impact factor: 2.629

Review 4.  Guidelines for the diagnosis and treatment of osteoarthritis in China (2019 edition).

Authors:  Zhiyi Zhang; Cibo Huang; Quan Jiang; Yi Zheng; Yi Liu; Shengyun Liu; Yingjuan Chen; Yifang Mei; Changhai Ding; Min Chen; Xin Gu; Dan Xing; Min Gao; Lan He; Zhizhong Ye; Lijun Wu; Jianhua Xu; Pinting Yang; Xuewu Zhang; Yue Zhang; Jinwei Chen; Jin Lin; Like Zhao; Mengtao Li; Wanling Yang; Yixin Zhou; Qing Jiang; Cong-Qiu Chu; Yaolong Chen; Weiya Zhang; Wei-Chung Tsai; Guanghua Lei; Dongyi He; Wei Liu; Yongfei Fang; Darong Wu; Jianhao Lin; Cheng-Chung Wei; Hsiao-Yi Lin; Xiaofeng Zeng
Journal:  Ann Transl Med       Date:  2020-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.